Authors
Latest:
Creating a Telehealth Experience For Postoperative AppointmentsLaura Rezac, MD and her colleagues evaluated a teledermatology postoperative follow-up model after Mohs Micrographic surgery.
Latest:
Jim Lee, MD, PhD, Reflects on New Research at AAD and Advances in Dermatology"It's an exciting time" in dermatology, said Lee, who reflects on late-breaker data and other research presented at the 2024 AAD Annual Meeting.
Latest:
Inpatient Dermatology Services, Encounters, and Physicians Experiencing Declines Across the USRegional disparities were highlighted in a study of inpatient dermatology encounters, locations, and providers from 2013 to 2019.
Latest:
My experience with surface radiotherapySuperficial radiation offers a newer, FDA-approved office-based option that is safe. Steven A. Davis, M.D., shares his experience using surface radiotherapy to treat his patients with non-melanoma skin cancer.
Latest:
Combining Surgical Precision With Immunological Innovation in Vitiligo TreatmentMaggi Ahmed, MD, PhD, demonstrated superior pigmentation outcomes and reduced CD8+ T cell numbers in her recent research results.
Latest:
Reviewing Multiple Subtypes of CHE and Delgocitinib as a Pan-JAK InhibitorChristopher Bunick, MD, PhD, discusses the multifactorial nature of chronic hand eczema, the burden of severe symptoms, and how delgocitinib restores skin integrity by targeting JAK/STAT pathways.
Latest:
Frontline Forum Part 4: Exploring Expert Perspectives on the Management of Acne VulgarisIn the final part of this Frontline Forum series, Neal Bhatia, MD; Dawn Eichenfield, MD, PhD; Lawrence Eichenfield, MD; Linda F. Stein Gold, MD; and Guy Webster, MD, PhD, discuss the practical and clinical considerations in the management of acne vulgaris, reviewing available treatment options and how to treat acne scars.
Latest:
Overview of Prurigo Nodularis for Practicing Dermatology CliniciansIt is crucial to better understand, diagnose, and manage this skin condition associated with significant quality-of-life impairment.
Latest:
Neoadjuvant Cemiplimab Induces Promising Pathologic Complete Response in CSCCNeoadjuvant treatment with cemiplimab led to near or complete disappearance of cutaneous squamous cell carcinoma in almost 64% of patients set to undergo surgery.
Latest:
Endoscopic Thoracic Sympathectomy Surgery for Hyperhidrosis: Patient and Physician PerspectivesPatient Cole Villaflor, his mother, and Michael Levy, MD, PhD, provide insights into Cole’s hyperhidrosis diagnosis and subsequent endoscopic thoracic sympathectomy surgery.
Latest:
Maral Kibarian Skelsey, MD, Shares Insights Into DermTech’s 2-GEP Assay SuccessDermTech’s study results demonstrated that in patients with Fitzpatrick skin types IV-VI, all 3 melanomas diagnosed by histopathology were correctly identified by the 2-GEP assay as positive for LINC00518 and PRAME.
Latest:
Take-Home PointsJoshua Zeichner, MD; Brittany Craiglow, MD; Elizabeth Swanson, MD; Vikash Oza, MD; and Raj Chovatiya, MD, PhD, provide take-home messages for dermatologists treating pediatric patients with atopic dermatitis.
Latest:
Anti-Cancer Immunotherapy Treatments Spark Common Skin-Related ToxicitiesDermatologist Laura Ferris, MD, PhD, discusses skin-related toxicities as a result of immunotherapies for the treatment and management of cancers.
Latest:
Best Practices for Recruiting Talented Staff for Your PracticeMedical practices must go beyond simply offering competitive salaries and benefits packages to attract new talent and keep their best clinicians and administrative staff working for them.
Latest:
Endoscopic Thoracic Sympathectomy Surgery for Hyperhidrosis: Patient and Physician PerspectivesPatient Cole Villaflor, his mother, and Michael Levy, MD, PhD, provide insights into Cole’s hyperhidrosis diagnosis and subsequent endoscopic thoracic sympathectomy surgery.
Latest:
No Kidding: Tips for Treating Pediatric ADWhat are the special considerations for treating pediatric atopic dermatitis? Test your knowledge and hear more from an expert.
Latest:
“Don’t Touch This”: Contact Dermatitis Insights and Updates from Matthew Zirwas, MDZirwas spoke with Dermatology Times to share the top clinical pearls and key takeaways from his discussion on contact dermatitis.
Latest:
Exploring the Intersection of Permanent Makeup and DermatologyWalter Liszewski, MD, shares insights into discrepancies between permanent makeup and decorative tattoos and which patients may benefit from permanent makeup.
Latest:
Organization Empowers Communities, Individuals to Celebrate the Skin They Are InCelebrating the Skin We're In seeks to advocate for health equity through community outreach and education efforts.
Latest:
Case 2: Female, 15 Years OldDr Bhutani presents the case of a 15-year-old female with long standing atopic dermatitis and discusses the importance of balancing parental preferences for "natural" agents with effective pharmaceutical options. She also reviews the significance of patient assistance programs in facilitating patient access to and affordability of pharmaceutical therapies.
Latest:
Seemal Desai, MD, Responds to Study Suggesting Melanoma is Overdiagnosed in White PatientsDesai emphasized that most dermatologists would rather biopsy a potential melanoma than miss one that could become deadly.
Latest:
Advancing Nail Disorder Care by Bridging Podiatry and DermatologyAt the 2024 SDPA Fall Conference, Tracey Vlahovic, DPM, highlighted the need for interdisciplinary collaboration in nail disorder management, underscoring the importance of mutual learning between podiatry and dermatology.
Latest:
Impact of Data on Generalized Pustular PsoriasisAaron S. Farberg, MD, and Jeffrey Crowley, MD, share take-home messages on the impact of the generalized pustular psoriasis study.
Latest:
The Psychosocial Impact of Skin Diseases in ChildrenAcne, molluscum, atopic dermatitis, and other dermatological disorders can be detrimental to quality of life for children and their families.
Latest:
Baldo Scassellati Sforzolini, MD, PhD, MBA: Expanding Nemolizumab’s AccessScassellati Sforzolini discusses the significance of Galderma’s nemolizumab receiving 4 additional filing acceptances for prurigo nodularis and atopic dermatitis.
